Effects of Rituximab on Brain Volume Loss in Pediatric Onset Remitting Relapsing Multiple Sclerosis (P3-1.017)
This study sought to determine the effects of rituximab on brain volume loss and expanded disability status scale (EDSS) in a cohort of pediatric patients with relapsing remitting multiple sclerosis (RRMS).
Authors
- Nilesh Desai (ORCID: https://orcid.org/0000-0001-9663-8655)
- Stephen F. Kralik (ORCID: https://orcid.org/0000-0001-7213-1761)
- Alfred Balasa
- Luning Wang (ORCID: https://orcid.org/0000-0003-0799-4469)
- David Chu (ORCID: https://orcid.org/0000-0001-9922-1994)
- Karla Salazar
Institutions
- Baylor College of Medicine (US)
- Texas Children's Hospital (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212115
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00